Early research (Phase 1)Ended earlyNCT04252430
What this trial is testing
RI Study to Assess and Compare the Pharmacokinetic Parameters of MD1003 in Renal Impaired Patients and Healthy Subjects
Who this might be right for
Healthy VolunteersImpaired Renal Function
MedDay Pharmaceuticals SA 24